Essential Drug Patents

Identifying and analysing the relevant patents for a medicine can be a difficult and time consuming exercise. Without the correct information, advocacy and procurement decisions can be ineffective.

Whereas previously we have provided patent landscapes in report format*, such information is easier to access and disseminate when in electronic form. This website has been created to host some of our earlier patent landscapes on essential medicines and ones we are currently working on in a searchable database format.

Where possible, we intend to update the information provided every 6 months. While we strive to make the landscapes as comprehensive as possible, very often they will be limited to certain countries. This is usually the result of the specific requests we have received or where information is readily available.

The first database available here maps out the relevant patents on current pegylated interferon treatments for Hepatitis C in several countries. The second database is an updated version of our landscape on HIV antiretroviral drug patents in China.